EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway

Xiudan Han, Jiao Wang, Ruilin Li, Meiling Huang, Guanru Yue, Lulu Guan, Yuanyuan Deng, Wei Cai, Jixiong Xu

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Xiudan Han und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, First Affiliated Hospital of Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Mesenchymal Stem Cells, Podocytes. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Natural Science Funds of China, Key Research and Development Programs by Science and Technology Department of JiangXi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of mesenchymal stem cells (MSCs) has become a new strategy for treating diabetic kidney disease (DKD). However, the role of placenta derived mesenchymal stem cells (P-MSCs) in DKD remains unclear. This study aims to investigate the therapeutic application and molecular mechanism of P-MSCs on DKD from the perspective of podocyte injury and PINK1/Parkin-mediated mitophagy at the animal, cellular, and molecular levels. Western blotting, reverse transcription polymerase chain reaction, immunofluorescence, and immunohistochemistry were used to detect the expression of podocyte injury-related markers and mitophagy-related markers, SIRT1, PGC-1α, and TFAM. Knockdown, overexpression, and rescue experiments were performed to verify the underlying mechanism of P-MSCs in DKD. Mitochondrial function was detected by flow cytometry. The structure of autophagosomes and mitochondria were observed by electron microscopy. Furthermore, we constructed a streptozotocin-induced DKD rat model and injected P-MSCs into DKD rats. Results showed that as compared with the control group, exposing podocytes to high-glucose conditions aggravated podocyte injury, represented by a decreased expression of Podocin along with increased expression of Desmin, and inhibited PINK1/Parkin-mediated mitophagy, manifested as a decreased expression of Beclin1, the LC3II/LC3I ratio, Parkin, and PINK1 associated with an increased expression of P62. Importantly, these indicators were reversed by P-MSCs. In addition, P-MSCs protected the structure and function of autophagosomes and mitochondria. P-MSCs increased mitochondrial membrane potential and ATP content and decreased the accumulation of reactive oxygen species. Mechanistically, P-MSCs alleviated podocyte injury and mitophagy inhibition by enhancing the expression of the SIRT1-PGC-1α-TFAM pathway. Finally, we injected P-MSCs into streptozotocin-induced DKD rats. The results revealed that the application of P-MSCs largely reversed the markers related to podocyte injury and mitophagy and significantly increased the expression of SIRT1, PGC-1α, and TFAM compared with the DKD group. In conclusion, P-MSCs ameliorated podocyte injury and PINK1/Parkin-mediated mitophagy inhibition in DKD by activating the SIRT1-PGC-1α-TFAM pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesMesenchymal Stem CellsPodocytesAnimalsFemalePregnancyRatsMitophagyPlacentaProtein KinasesSirtuin 1StreptozocinTranscription FactorsUbiquitin-Protein LigasesPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Stichwörter der Autor:innen

SIRT1-PGC-1α-TFAM pathwaydiabetic kidney diseasemitophagyplacenta derived mesenchymal stem cellspodocyte injury

Substanzen

Protein KinasesSirtuin 1StreptozocinTranscription FactorsUbiquitin-Protein LigasesSirt1 protein, ratTfam protein, ratPpargc1a protein, ratPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
  • Jiangxi Clinical Research Center for Endocrine and Metabolic Disease, Nanchang 330006, China.
  • Jiangxi Branch of National Clinical Research Center for Metabolic Disease, Nanchang 330006, China.
  • Department of Cell Biology, School of Medicine, Nanchang University, Nanchang 330006, China.

Förderung

  • National Natural Science Foundation of China
  • National Natural Science Funds of China
  • Key Research and Development Programs by Science and Technology Department of JiangXi Province
  • Provincial Science and Technology Innovation Base Plan-Provincial Clinical Medical Research Center

Zitieren

APA

Han, X., Wang, J., Li, R., Huang, M., Yue, G., Guan, L., Deng, Y., Cai, W., & Xu, J. (2023). Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054696

Vancouver

Han X, Wang J, Li R, Huang M, Yue G, Guan L, et al. Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054696

BibTeX
@article{Han2023,
  author = {Han, Xiudan and Wang, Jiao and Li, Ruilin and Huang, Meiling and Yue, Guanru and Guan, Lulu and Deng, Yuanyuan and Cai, Wei and Xu, Jixiong},
  title = {Placental Mesenchymal Stem Cells Alleviate Podocyte Injury in Diabetic Kidney Disease by Modulating Mitophagy via the SIRT1-PGC-1alpha-TFAM Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054696}
}
Kostenlos starten →